









Markets
/
Stocks
/
nasdaq-prme
/

Prime Medicine Inc

PRME

5.120USD

+0.470+10.11%

Close 09/18, 16:00（ET）Quotes delayed by 15 min

688.61MMarket Cap

LossP/E TTM



Prime Medicine Inc

5.120

+0.470+10.11%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

Total revenue

--1.11M

146.02%1.45M

--2.18M

--209.00K

--0.00

--591.00K

----

--0.00

----

--0.00

Revenue

--1.11M

146.02%1.45M

--2.18M

--209.00K

--0.00

--591.00K

----

--0.00

----

--0.00

Operating expenses

-2.12%54.49M

10.04%53.85M

-31.80%46.41M

5.79%54.44M

23.01%55.67M

22.23%48.93M

75.89%68.04M

62.56%51.46M

72.05%45.26M

101.19%40.03M

-35.60%38.69M

203.59%31.66M

228.16%26.30M

234.14%19.90M

2213.28%60.08M

--10.43M

--8.02M

--5.96M

--2.60M

R&D expenses

-3.94%41.38M

7.38%40.56M

-17.74%34.10M

-1.53%40.34M

24.49%43.07M

22.33%37.77M

42.66%41.46M

63.56%40.97M

82.68%34.60M

125.78%30.88M

-45.05%29.06M

238.47%25.05M

232.57%18.94M

199.54%13.68M

4100.87%52.89M

--7.40M

--5.70M

--4.57M

--1.26M

Depreciation, depletion, and amortization

21.20%1.86M

29.28%1.70M

37.69%1.72M

26.05%1.56M

37.57%1.54M

25.00%1.31M

43.33%1.25M

95.88%1.24M

160.00%1.12M

259.04%1.05M

190.00%870.00K

277.84%631.00K

252.46%430.00K

193.00%293.00K

1204.35%300.00K

--167.00K

--122.00K

--100.00K

--23.00K

Other operating expenses

----

--13.50M

----

Operating profit

4.12%-53.38M

-8.38%-52.39M

35.01%-44.22M

-5.39%-54.23M

-23.01%-55.67M

-20.75%-48.34M

-75.89%-68.04M

-62.56%-51.46M

-72.05%-45.26M

-101.19%-40.03M

35.60%-38.69M

-203.59%-31.66M

-228.16%-26.30M

-234.14%-19.90M

-2213.28%-60.08M

---10.43M

---8.02M

---5.96M

---2.60M

Net non-operating interest income (expenses)

Non-operating interest income

21.60%743.00K

--1.18M

--1.54M

--697.00K

--611.00K

----

Gains from sale of securities

-64.33%530.00K

--339.00K

--306.00K

--885.00K

--1.49M

----

Special income (expenses)

73.77%-505.00K

-190.57%-1.06M

-90.71%59.00K

113.62%215.00K

-831.94%-1.93M

168.55%1.17M

137.16%635.00K

-188.26%-1.58M

107.06%263.00K

62.07%-1.70M

-16.58%-1.71M

121.41%1.79M

-138.19%-3.72M

94.48%-4.49M

-209.08%-1.47M

---8.35M

--9.75M

---81.32M

--1.34M

Other non-operating income (expenses)

-53.85%18.00K

-97.61%37.00K

-97.56%43.00K

-103.74%-83.00K

-98.52%39.00K

-27.49%1.55M

90.60%1.77M

205.22%2.22M

1009.24%2.64M

19309.09%2.13M

7616.67%926.00K

72900.00%728.00K

23700.00%238.00K

--11.00K

-97.84%12.00K

---1.00K

--1.00K

--0.00

--555.00K

Income before tax

5.17%-52.59M

-13.73%-51.89M

35.60%-42.28M

-3.35%-52.52M

-30.95%-55.46M

-15.22%-45.63M

-66.32%-65.64M

-74.40%-50.82M

-42.18%-42.35M

-62.48%-39.60M

35.85%-39.47M

-55.14%-29.14M

-1817.99%-29.79M

72.07%-24.37M

-8715.19%-61.53M

---18.78M

--1.73M

---87.28M

---698.00K

Income tax

100.00%0.00

-100.00%0.00

--0.00

100.00%0.00

-532.26%-134.00K

166.34%134.00K

100.00%0.00

-150.94%-108.00K

107.01%31.00K

62.03%-202.00K

-113.47%-186.00K

108.95%212.00K

-139.53%-442.00K

13.50%-532.00K

-26.03%1.38M

---2.37M

--1.12M

---615.00K

--1.87M

Income after tax

4.95%-52.59M

-13.39%-51.89M

35.60%-42.28M

-3.57%-52.52M

-30.53%-55.33M

-16.15%-45.76M

-67.10%-65.64M

-72.77%-50.71M

-44.42%-42.38M

-65.26%-39.40M

37.56%-39.28M

-78.83%-29.35M

-4864.29%-29.35M

72.49%-23.84M

-2352.67%-62.91M

---16.41M

--616.00K

---86.66M

---2.56M

Net income from continuous operations

4.95%-52.59M

-13.39%-51.89M

35.60%-42.28M

-3.57%-52.52M

-30.53%-55.33M

-16.15%-45.76M

-67.10%-65.64M

-72.77%-50.71M

-44.42%-42.38M

-65.26%-39.40M

37.56%-39.28M

-78.83%-29.35M

-4864.29%-29.35M

72.49%-23.84M

-2352.67%-62.91M

---16.41M

--616.00K

---86.66M

---2.56M

Net income attributable to controlling interests

4.95%-52.59M

-13.39%-51.89M

35.60%-42.28M

-3.57%-52.52M

-30.53%-55.33M

-16.15%-45.76M

-61.69%-65.64M

-41.99%-50.71M

-18.92%-42.38M

-31.04%-39.40M

41.40%-40.60M

-56.80%-35.71M

-745.17%-35.64M

65.78%-30.06M

-1970.32%-69.27M

---22.77M

---4.22M

---87.85M

---3.35M

Preferred share dividend

----

-100.00%0.00

-79.35%1.31M

-0.02%6.36M

30.21%6.29M

421.27%6.22M

714.60%6.36M

--6.36M

--4.83M

--1.19M

--781.00K

Net income attributable to common shareholders

4.95%-52.59M

-13.39%-51.89M

35.60%-42.28M

-3.57%-52.52M

-30.53%-55.33M

-16.15%-45.76M

-61.69%-65.64M

-41.99%-50.71M

-18.92%-42.38M

-31.04%-39.40M

41.40%-40.60M

-56.80%-35.71M

-745.17%-35.64M

65.78%-30.06M

-1970.32%-69.27M

---22.77M

---4.22M

---87.85M

---3.35M

Basic earnings per share

12.30%-0.41

9.49%-0.40

54.51%-0.32

20.57%-0.44

0.92%-0.46

0.97%-0.44

-85.06%-0.71

-45.84%-0.55

-24.01%-0.47

-38.80%-0.44

47.76%-0.38

-56.81%-0.38

-745.21%-0.38

65.78%-0.32

-1970.26%-0.73

---0.24

---0.04

---0.93

---0.04

Diluted earnings per share

12.30%-0.41

9.49%-0.40

54.51%-0.32

20.57%-0.44

0.92%-0.46

0.97%-0.44

-85.06%-0.71

-45.84%-0.55

-24.01%-0.47

-38.80%-0.44

47.76%-0.38

-56.81%-0.38

-745.21%-0.38

65.78%-0.32

-1970.26%-0.73

---0.24

---0.04

---0.93

---0.04

Dividend per share

--0.00

Currency unit

USD

Audit opinions

KeyAI

